Molecular Immunology Market Analysis and Reports | UK Conference Series

Market Analysis - Molecular Immunology 2018

Market Value on Molecular Medicine and Immunology Research

The global Molecular Medicine market in UK is $4.8 billion where as it is $11 billion in USA. The market value for Molecular Medicine research in 2018 throughout the world is $24 billion.

Molecular Medicine conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates, Doctors, and talented student communities in the field of medicine under a single roof where networking and global partnering happens for the acceleration of future research. Following are the statistics percentage wise:

Statistics of Physicians, Researchers and Academicians working on Molecular Medicine and Immunology section.









Molecular Medicine on Healthcare Industries.

The worldwide injectable medication conveyance advancements business sector was esteemed at $22.5 billion in 2012, it is relied upon to reach $45 billion by 2018 at a CAGR of 14.0% from 2012 to 2018. Injectable medication conveyance advancements are the mix of two noteworthy portions: gadgets and definitions. This business sector understanding report on Liposomes gives knowledge into worldwide Liposomes market. The concentrate additionally gives data with respect to items and innovations in the field of Liposomes. Business profiles of 46 noteworthy organizations are examined in the report. The report covers more than 330 organizations that are occupied with molecular medicine research and supply of items and/or administrations. The worldwide liposome mediated molecular medicine business sector is anticipated at a CAGR of 16% through 2005-2018.

Molecular Biomarkers for Cancer Detection market is expected to reach $30.6 billion globally by 2020

Molecular biomarkers are the biomarkers usually in molecular form. Molecular biomarkers take part in various purposes, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety evaluation. The molecular biomarkers are exclusively being developed and validated to be used in drug development and used to support approval of drug products. Molecular biomarkers are mainly classified into Protein biomarkers, Nucleic acid based biomarkers, Lipid biomarkers and Small molecule biomarkers. Almost every pharmaceutical company has been developing molecular biomarker programs. There has been a rapid increase in the number of molecular biomarkers used in drug delivery over the last decade. With the growing incidence cancer worldwide and rising economic burden caused by cancer is expected to increase demand for early detection of cancer.  As per the CDC (Centers for Disease Control and Prevention) by 2025, 19.3 million cases of cancer cases are expected to be diagnosed each year which in turn is supposed to increase demand for early detection of cancer. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.

Major Immunology Associations Globally

Major Hospitals in Europe

  • Assistance Publique Hôpitaux de Paris
  • University Clinic Heidelberg Universittsklinikum Heidelberg
  • Erasmus Medisch Centrum Universitait Medisch Centrum Rotterdam
  • Asklepios Klinikum Bad Abbach
  • Leiden University Medical Center / Leids Universitair Medisch Centrum
  • Centre Hospitalier Universitaire Vaudois Lausanne
  • Hôpitaux Universitaires de Geneve
  • Universitätsklinikum Hamburg Eppendorf
  • Universitätsklinikum und Medizinische Fakultät Tübingen
  • Sahlgrenska University Hospital
  • Universitätsklinikum Freiburg
  • Universitätsklinikum Jena Klinikum der Friedrich Schiller Universität
  • Klinik und Poliklinik für Hals Nasen Ohrenheilkunde Ludwig Maximilians Universität München
  • Instytut Psychiatrii i Neurologii
  • Universitair Ziekenhuis Leuven

Top Global Immunology Universities

  •   Harvard University
  •   University of California--San Francisco
  •   Stanford University
  •   Yale University
  •   Johns Hopkins University
  •   Washington University in St. Louis
  •   Duke University
  •   University of Pennsylvania
  •   University of Texas Southwestern Medical Center-Dallas

Top Companies

  • Actelion
  • Agilent
  • Alexion
  • Amgen
  • AstraZeneca
  • Bayer
  • Biogen
  • BioMarin
  • Bristol-Myers Squibb
  • Celgene
  • Daiichi Sankyo
  • Gilead Sciences
  • Glaxo Smith Kline
  • Illumina
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
  • Regeneron
  • Roche
  • Sanofi Genzyme
  • Takeda
  • Vertex

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023.
Europe precision medicine market size, by application, 2013 - 2023 (USD Million)

9th Molecular Immunology & Immunogenetics Congress to be held during March 08-09, 2018 in London, UK with the theme of Novel Approaches for Immune-mediated Diseases & Advancements in Existing Therapies

The global immunology treatment market is set to expand, from $61.5 billion in 2015 to reach $74.2 billion in 2022 at a compound annual growth rate of 2.71%.

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. 

The geographic analysis reveals that North America will account for the largest share of the global biomarkers market in 2015. Growth in this market can be attributed to strong growth trends in pharmaceutical companies and CROs. The Asian regional segment is expected to register double-digit growth from 2015 to 2020 owing to the expansion of leading biomarker companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of the global R&D expenditure in 2010.

Target Audience

  • Immunology  and Molecular Biology Students, Scientists
  • Immunology and Biochemistry Researchers
  • Immunology, Microbiology Faculty
  • Young Researchers
  • Medical Colleges, Hospitals
  • Physicians/Consultants
  • Geneticist, Bioinformatician
  • Immunology, Cellular Biology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  •  Manufacturing Medical Devices Companies

Why to attend?

  • Best platform to develop new partnership & collaborations.
  • Best location to speed up your route into every territory in the World.
  • 89% our conference attendees are the Key contact in their labs purchasing decisions.
  • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
  • Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees.
  • Network development with both Academia and Business.